Inhibrx Biosciences Management
Management criteria checks 0/4
Inhibrx Biosciences' CEO is Mark Lappe, appointed in May 2024, has a tenure of less than a year. directly owns 5.26% of the company’s shares, worth $9.49M. The average tenure of the management team and the board of directors is 0.6 years and 0.6 years respectively.
Key information
Mark Lappe
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 5.3% |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO
Mark Lappe (57 yo)
less than a year
Tenure
Mr. Mark Paul Lappe serves as Chief Executive Officer, President and Chairperson of the board of directors at Inhibrx Biosciences, Inc. since May 30, 2024. He co-founded Efficacy Capital Limited in 2004 se...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Chairman | less than a year | no data | 5.26% $ 9.5m | |
| Executive VP | less than a year | no data | no data | |
| Executive VP | less than a year | no data | no data | |
| Executive VP & Chief Scientific Officer | less than a year | no data | 3.55% $ 6.4m | |
| VP & General Counsel | less than a year | no data | no data | |
| Vice President of Marketing & Commercial Planning | less than a year | no data | no data | |
| Executive VP & Chief Clinical Operations Officer | less than a year | no data | no data | |
| Executive VP & Chief Clinical Development Officer | less than a year | no data | no data | |
| Executive VP and Chief Commercial & Business Development Officer | less than a year | no data | no data | |
| Executive Vice President of Translational Sciences | less than a year | no data | no data |
0.6yrs
Average Tenure
50.5yo
Average Age
Experienced Management: INBX's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Chairman | less than a year | no data | 5.26% $ 9.5m | |
| Independent Director | less than a year | no data | 1.03% $ 1.9m | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | 7.56% $ 13.6m | |
| Member of INBRX-101 Scientific Advisory Board | less than a year | no data | no data | |
| Member of INBRX-101 Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Member of INBRX-101 Scientific Advisory Board | less than a year | no data | no data | |
| Member of INBRX-101 Scientific Advisory Board | less than a year | no data | no data | |
| Member of INBRX-101 Scientific Advisory Board | less than a year | no data | no data | |
| Member of INBRX-101 Scientific Advisory Board | less than a year | no data | no data |
0.6yrs
Average Tenure
57yo
Average Age
Experienced Board: INBX's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.